A Phase II Randomized Study of Cidofovir Versus Best Supportive Care for Polyomavirus Hominis Type I (BK) Virus Related Hemorrhagic Cystitis After Stem Cell Transplant.

Trial Profile

A Phase II Randomized Study of Cidofovir Versus Best Supportive Care for Polyomavirus Hominis Type I (BK) Virus Related Hemorrhagic Cystitis After Stem Cell Transplant.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 26 May 2017

At a glance

  • Drugs Cidofovir (Primary)
  • Indications Haemorrhagic cystitis; Polyomavirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
    • 18 May 2016 Status changed from recruiting to active, no longer recruiting.
    • 29 Nov 2012 New source identified and integrated (M.D. Anderson Cancer Center; 2010-0518).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top